Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
47.60
-1.40 (-2.86%)
At close: Nov 20, 2025, 4:00 PM EST
47.04
-0.56 (-1.18%)
After-hours: Nov 20, 2025, 7:58 PM EST
Novo Nordisk Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$60.50
Upside
+27.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Oct 27, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $50 → $55 | Hold | Maintains | $50 → $55 | +15.55% | Oct 14, 2025 |
| HSBC | HSBC | Hold → Strong Buy Upgrades $70 | Hold → Strong Buy | Upgrades | $70 | +47.06% | Oct 2, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $59 → $47 | Hold → Sell | Downgrades | $59 → $47 | -1.26% | Sep 29, 2025 |
| Berenberg | Berenberg | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 17, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $105 → $70 | Strong Buy | Maintains | $105 → $70 | +47.06% | Aug 19, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 5, 2025 |
| HSBC | HSBC | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 31, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 30, 2025 |
| TD Cowen | TD Cowen | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +120.59% | Jun 18, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $105 → $64 | Buy → Hold | Downgrades | $105 → $64 | +34.45% | Apr 17, 2025 |
| UBS | UBS | Strong Sell → Strong Buy Upgrades n/a | Strong Sell → Strong Buy | Upgrades | n/a | n/a | Jan 8, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $156 → $105 | Buy | Maintains | $156 → $105 | +120.59% | Dec 23, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $155 → $105 | Strong Buy | Maintains | $155 → $105 | +120.59% | Dec 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +236.13% | Nov 6, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $160 → $156 | Buy | Maintains | $160 → $156 | +227.73% | Oct 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.